Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2019 | CARPALL and AMELIA: ongoing data for CAR-T in ALL

We spoke to Sara Ghorashian, PhD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK, about the CARPALL (NCT02443831) and AMELIA (NCT03289455) trials. CARPALL is looking at CD19 CAR-T for young patients with relapsed acute lymphoblastic leukemia (ALL), while AMELIA is investigating CD19/22 CAR T-cells (AUTO3) for the treatment of relapsed/refractory B-cell ALL. This interview took place at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK.